Stryker Corporation
SYKHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, Stryker Corporation (SYK) is listed under Medical Devices. At a $116.96B market cap, Stryker Corporation ranks as a large-cap company within healthcare. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Market Cap
$116.96B
Beta
0.81
P/E (TTM)
35.35
P/E (Fwd)
18.25
EPS (TTM)
$8.63
EPS (Fwd)
$16.72
ROE
15.2%
ROA
7.7%
Cash
$2.96B
Total Debt
$15.23B
Free CF
$4.36B
52W Change
-19.9%
Annual Financials
Cash vs Debt
Stryker Corporation carries $15.23B in total debt against $2.96B in cash reserves — debt is roughly 5.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $4.36B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 15.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $18.45B (2022) to $25.12B (2025), reflecting a 36% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Stryker Corporation and its sector.